Drug Transporter (DT) Information

General Information of DT
DT ID DTD0457
Gene Name SLC6A5
Protein Name Sodium- and chloride-dependent glycine transporter 2
Gene ID
9152
UniProt ID
Q9Y345
TCDB ID
2.A.22.2.10
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 4XPB_A; 6VRH_A

Identity: 46.248% ; 41.791%

Minimized Score: -1433.714 kcal/mol

Detail: Structure Info

Synonyms GlyT-2; GlyT2; HKPX3; SLC6A5; Solute carrier family 6 member 5
DT Family Neurotransmitter:Sodium Symporter (NSS) Family ;
Tissue Specificity Expressed in medulla, and to a lesser extentin spinal cord and cerebellum.
Function This transporter terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals and may be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses.
Disease(s) Neurogenic shock [ICD-11: MG40.Y]
Traumatic brain injury [ICD-11: NA07.Z]
Endogenous Substrate(s) Cl-; Na+
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            3 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Glycine
 Approved Drug Info Dietary shortage 5B7Z [1]
Methylphenidate
 Approved Drug Info Traumatic brain injury NA07.Z [2]
Norepinephrine
 Approved Drug Info Septic shock 1G41 [3]
References
1 Mutations in the GlyT2 gene (SLC6A5) are a second major cause of startle disease. J Biol Chem. 2012 Aug 17;287(34):28975-85.
2 SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol Aspects Med. 2013 Apr-Jun;34(2-3):197-219.
3 SLC6A2 Gene (Protein Coding).

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.